Oncolytics Biotech
ONCY
#10284
Rank
S$68.28 M
Marketcap
S$0.52
Share price
-7.21%
Change (1 day)
-62.64%
Change (1 year)

Oncolytics Biotech (ONCY) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : S$17.67 Million

According to Oncolytics Biotech 's latest financial reports the company's total liabilities are S$17.67 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oncolytics Biotech - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$11.22 M4.62%
2022-12-31S$10.73 M3.46%
2021-12-31S$10.37 M4.25%
2020-12-31S$9.95 M-51.22%
2019-12-31S$20.4 M134.65%
2018-12-31S$8.69 M-17.11%
2017-12-31S$10.48 M139.3%
2016-12-31S$4.38 M58.65%
2015-12-31S$2.76 M-28.08%
2014-12-31S$3.84 M-46.28%
2013-12-31S$7.15 M-20.24%
2012-12-31S$8.96 M8.68%
2011-12-31S$8.25 M156.04%
2010-12-31S$3.22 M-42.86%
2009-12-31S$5.63 M5.76%
2008-12-31S$5.33 M31.04%
2007-12-31S$4.06 M11.69%
2006-12-31S$3.64 M38.36%
2005-12-31S$2.63 M76.36%
2004-12-31S$1.49 M10.15%
2003-12-31S$1.35 M-24.23%
2002-12-31S$1.78 M-57.62%
2001-12-31S$4.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
S$137.70 B 778,921.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$83.49 B 472,280.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
S$0.23 B 1,224.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
S$30.42 M 72.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$41.00 B 231,869.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
S$92.46 M 423.11%๐Ÿ‡บ๐Ÿ‡ธ USA